Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the European Commission (EC) has granted approval for Ordspono™ (odronextamab) to treat adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL) who have undergone…
Bristol Myers Squibb (NYSE: BMY) has announced that it will present research findings from its comprehensive cardiovascular portfolio at the European Society of Cardiology (ESC) Congress, scheduled for August 30 – September 2, 2024, in London, England. The presentations will…
ADVI Health is excited to announce its acquisition of Partnership for Health Analytic Research (PHAR), a leading consultancy specializing in global health technology assessment (HTA) and health economics and outcomes research (HEOR). Known for delivering impactful, data-driven insights to major…
In 2017, Maria Morais began experiencing severe abdominal pain, which led to gall bladder surgery. However, when the procedure failed to alleviate her discomfort, follow-up tests revealed alarmingly high liver enzyme levels. As a registered nurse, Maria recognized that something…
Aetna Better Health® of Illinois, a CVS Health® company (NYSE: CVS), has announced a generous community investment of $100,000 to the Safer Foundation. This funding aims to assist in housing unhoused families in Chicago. To date, Aetna’s investment has enabled…
Eisai Co., Ltd. (Tokyo, CEO: Haruo Naito) and Biogen Inc. (Cambridge, Massachusetts, CEO: Christopher A. Viehbacher) have announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in Great Britain has granted Marketing Authorization for their humanized amyloid-beta (Aβ) monoclonal…
Moderna, Inc. (NASDAQ) has announced that the European Commission (EC) has granted marketing authorization for mRESVIA® (mRNA-1345), an mRNA vaccine designed to protect adults aged 60 and older from lower respiratory tract disease caused by RSV (respiratory syncytial virus). This…
Astellas Pharma Inc. (TSE: 4503), led by President and CEO Naoki Okamura, has announced that the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) has granted approval for PADCEV™ (enfortumab vedotin). This approval allows the use…
Genmab A/S (Nasdaq: GMAB) has announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) who have undergone two or more lines…
Lupin Limited, a leading global pharmaceutical company, has announced that it has received approval from Health Canada for its biosimilar Pegfilgrastim. The product, to be marketed under the brand name Armlupeg®, will be manufactured at Lupin’s Biotech facility in Pune,…
Amgen (NASDAQ: AMGN) has announced that Otezla® (apremilast) is now available in the U.S. for pediatric use. Earlier this year, the U.S. Food and Drug Administration (FDA) approved Otezla for treating moderate to severe plaque psoriasis in children and adolescents…
Eli Lilly and Company (NYSE: LLY) announced today positive top-line results from the SURMOUNT-1 three-year study, which evaluated the long-term efficacy and safety of tirzepatide (Zepbound® and Mounjaro®) for weight management and delaying the progression to diabetes in adults with…